Compass Diversified Holdings: 2025 Q3 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025, for Compass Diversified Holdings (CODI). The filing is significantly impacted by the "Lugano Investigation" into the financial, accounting, and inventory practices of its subsidiary, Lugano Holding Inc. Consequently, the Company restated its financial statements for 2022, 2023, 2024, and interim periods in 2025. The filing was delayed until the investigation concluded and restatements were completed. As of November 16, 2025, Lugano filed for Chapter 11 bankruptcy and was deconsolidated from the Company's financial statements.
Key Financial Metrics (Nine Months Ended Sept 30, 2025)
| Metric | 2025 (Restated) | 2024 (Restated) |
|---|---|---|
| Net Revenues | $1,405.0 million | $1,294.1 million |
| Gross Profit | $612.3 million | $559.8 million |
| Operating Loss | $(34.9) million | $3.7 million (Income) |
| Net Loss (Continuing Ops) | $(217.3) million | $(257.4) million |
| Net Loss Attributable to Holdings | $(155.2) million | $(165.3) million |
| Interest Expense, Net | $(136.7) million | $(86.5) million |
| Cash and Equivalents | $61.1 million | $59.7 million (Year End 2024) |
| Total Debt (Current) | $1,878.9 million | $1,774.3 million |
Note: All debt is classified as current due to covenant non-compliance and forbearance agreements.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net revenues increased 8.6% year-over-year, driven by acquisitions (The Honey Pot Co., Lifoam) and growth at 5.11 and Lugano, partially offset by declines at Arnold and Sterno.
- Impairment Charges: The Company recorded $31.5 million in impairment expense in 2025, primarily related to Lugano's long-lived assets ($29.5 million PP&E and $1.9 million right-of-use assets) following the investigation findings. This compares to $8.2 million in 2024 (Velocity goodwill impairment).
- Interest Expense Surge: Interest expense increased 58% to $136.7 million. This includes $22.8 million in paid-in-kind (PIK) interest related to an Indenture Forbearance Agreement and higher rates on Lugano financing arrangements.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased $70.5 million, largely due to $36.7 million in costs associated with the Lugano Investigation and corporate legal fees.
- Segment Performance: Lugano reported a segment operating loss of $71.2 million (vs. $45.4 million loss in 2024) due to impairments. Altor saw revenue growth of 51.8% due to the Lifoam acquisition.
Guidance, Outlook, Risks, and Contingencies
Going Concern: Management has concluded that substantial doubt exists regarding the Company's ability to continue as a going concern within one year. This is due to recent covenant non-compliance, the timing of the next financial covenant test (March 31, 2026), and reliance on uncommitted initiatives (divestitures, cost reductions) to improve liquidity.
Debt and Covenants: The Company has entered into multiple forbearance agreements (First through Fifth) with lenders regarding its 2022 Credit Facility and Senior Notes. While a Fifth Amendment (Dec 19, 2025) waived existing defaults and reset covenants, the Company must maintain a Consolidated Total Leverage Ratio below 4.50:1.00 by June 30, 2026, or face milestone fees and potential acceleration of debt.
Liquidity: Cash distributions on common shares were suspended in May 2025. Preferred share distributions continue. The Company relies on operating cash flows from subsidiaries (excluding Lugano) and potential asset sales to meet obligations.
Legal and Regulatory:
- Lugano Bankruptcy: Lugano filed Chapter 11 on November 16, 2025. The Company has recorded accruals for vendor obligations and financing arrangements but cannot estimate additional losses from pending litigation.
- Investigations: Ongoing investigations by the SEC and DOJ regarding the Lugano matters and financial restatements.
- Litigation: Multiple securities class actions and derivative suits are pending against the Company and its officers/directors.
Investor Verification Checklist
- Covenant Compliance: Verify the Company's ability to meet the reset financial covenants (Leverage Ratio < 4.50:1) by the next testing date (June 30, 2026) to avoid debt acceleration.
- Lugano Recovery: Assess the potential recovery value from Lugano's Chapter 11 proceedings and the impact of the deconsolidation on future financial statements.
- Management Fee Clawback: Confirm the status of the estimated $42.7 million in overpaid management fees to the Manager and the mechanism for recovery via future fee offsets.
- Liquidity Runway: Monitor cash burn rates and the execution of planned deleveraging transactions (divestitures) given the "substantial doubt" going concern warning.
- Legal Exposure: Track the resolution of the SEC/DOJ investigations and the outcome of securities class actions, which could result in significant liabilities.